Stock screenerAll disclosures →
EDGAR →
RLYB
Conviction 80HealthcareScan · Thu, Jun 25, 2026Bearish marubozu
RLYB$15.73-1.19%
ResistanceSupportVol 14Insider buy4
2
4
4
2
6
2
4
Vol MA14 44.89K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price15.73
Change-1.19%
Gap-0.13%
Rel volume0.57×
Avg volume71K
Avg $ vol1.15M
SMA 2015.84
SMA 5013.50
SMA 2005.52
Price vs 50+16.51%
Price vs 200+184.75%
MA stackbullish
50/200 cross—
Supertrendup · 14.32
RSI (14)59
MACD hist-0.20
MACD cross—
Stoch %K / %D13 / 17
ADX (14)47
+DI / −DI29 / 12
RSI divergence—
MACD divergence—
ATR %+3.55%
ADR %3.11%
52w high16.87
52w low0.3229
From 52w high-6.76%
Above 52w low+4771.48%
New 52w highNo
SqueezeOff
Bollinger width12.83%
%B0.44
Donchian pos45.19%
Donchian high17.57
Donchian low14.21
AVWAP (52w high)16.36
vs AVWAP high-3.87%
AVWAP (52w low)1.72
vs AVWAP low+813.58%
OBV trendFlat
Chaikin MF (20)-0.32
Today vs 20d0.57×
Avg vol (14d)44.89K
Avg vol (20d)71K
Avg $ vol (20d)1.15M
Market cap83.34M
RS 3m (vs SPY)+71.36%
RS 6m (vs SPY)+1920.29%
RS line new highNo
Trend template8/8
Technical rank92.0
1 week-1.19%
1 month+7.01%
3 months+82.38%
6 months+1907.66%
1 year+4151.35%
YTD+2123.95%
P/E-9.28
P/B1.66
P/S97.13
P/FCF-2.80
EPS-1.59
Div yield—
ROE-17.86%
ROA-16.48%
Debt/Eq—
Current12.92
EV/EBITDA-1.27
Gross margin—
Net margin—
Rev growth34.91%
EPS growth84.46%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value42.04M
Revenue212K
Net income-8.28M
Gross profit—
Free cash flow-29.81M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees9
ListedThu, Jul 29, 2021
Free float1.97M
Float %37.2%
Short interest586.91K
Days to cover12.0d
Short volume37.1%
Squeeze score65 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank92.0 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish marubozu
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RLYB
No recent disclosed trades by Congress in RLYB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RLYB · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Schneeberger Daniel 10% owner · Common Stock · 2026-05-19 | Buy | 200 | $3K | 2026-05-19 | 2026-05-20 |
Schneeberger Daniel 10% owner · Common Stock · 2026-05-19 | Buy | 10K | $140K | 2026-05-19 | 2026-05-20 |
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-05-19 | Buy | 200 | $3K | 2026-05-19 | 2026-05-20 |
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-05-19 | Buy | 10K | $140K | 2026-05-19 | 2026-05-20 |
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-05-18 | Buy | 6.01K | $84K | 2026-05-18 | 2026-05-20 |
Schneeberger Daniel 10% owner · Common Stock · 2026-05-18 | Buy | 6.01K | $84K | 2026-05-18 | 2026-05-20 |
Schneeberger Daniel 10% owner · Common Stock · 2026-05-15 | Buy | 200 | $3K | 2026-05-15 | 2026-05-15 |
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-05-15 | Buy | 100 | $1K | 2026-05-15 | 2026-05-15 |
ADAR1 Capital Management, LLC 10% owner · Common Stock · 2026-05-15 | Buy | 200 | $3K | 2026-05-15 | 2026-05-15 |
Schneeberger Daniel 10% owner · Common Stock · 2026-05-15 | Buy | 100 | $1K | 2026-05-15 | 2026-05-15 |
SEC filings
EDGAR filings in RLYB · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.